News & Perspective

Jul 31, 2012

Jul 31, 2012

Fauci urges continuing pause on risky H5N1 studies

(CIDRAP News) – The head of the US agency that funds much influenza research today called on scientists to continue their voluntary moratorium on certain kinds of potentially hazardous H5N1 research, saying they need to better address public concerns about the studies, according to news reports from a flu meeting in New York City.

Jul 24, 2012

Jul 24, 2012

WHO offers some guidance on risky H5N1 studies

(CIDRAP News) – The World Health Organization (WHO) has offered some brief, general guidance on safety and security in research on laboratory-modified H5N1 viruses, mainly stressing that researchers should follow existing guidelines and gain authorization from their governments.

Jun 21, 2012

Jun 21, 2012

Fouchier study reveals changes enabling airborne spread of H5N1

(CIDRAP News) – A study showing that it takes as few as five mutations to turn the H5N1 avian influenza virus into an airborne spreader in mammals—and that launched a historic debate on scientific accountability and transparency—was released today in Science, spilling the full experimental details that many experts had sought to suppress out of concern that publishing them could lead to the unleashing of a dangerous virus.

Feb 29, 2012

Feb 29, 2012

With new data, NSABB may revisit H5N1 studies

(CIDRAP News) – The mutant H5N1 virus generated in one of two controversial studies was less lethal and contagious than has been generally understood, and the US government's biosecurity advisory committee will be asked to examine new and clarified data from the study, scientists and government officials revealed today.

Jan 20, 2012

Jan 20, 2012

Researchers announce pause in controversial H5N1 studies

(CIDRAP News) – Leading influenza researchers from around the world, faced with a relentless controversy over experiments dealing with potentially dangerous H5N1 viruses, today announced a 60-day pause in such research to allow time to discuss its risks, benefits, and oversight.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»